Drug details

Aimovig (erenumab-aooe injection, for subcutaneous use)

type of CGRP Monoclonal Antibodies

Aimovig (erenumab-aooe) Injection is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.

The drug is often used to treat Migraine .

This drug may have the following side effects:

• injection site reactions (pain or redness),
• constipation, and
• muscle spasms or
• cramps

The following drugs are related to Aimovig, either as a replacement or used together:

• Ajovy (fremanezumab-vfrm injection)
• Qulipta (atogepant tablets)
• Trudhesa (dihydroergotamine mesylate nasal spray)
• Emgality (galcanezumab-gnlm injection)
• Vyepti (eptinezumab-jjmr injection for intravenous use)
• Migergot (ergotamine tartrate and caffeine suppositories)
• Reyvow (lasmiditan tablets)
• RizaFilm (rizatriptan oral film)